Cohen & Steers Reports Mixed Q4 2025 Results with GAAP EPS Decline Due to One-Time Costs
Summary
Cohen & Steers reported Q4 2025 results with GAAP diluted EPS of $0.68, a decrease from prior periods, largely due to $10.8 million in non-recurring expenses. However, adjusted diluted EPS remained stable at $0.81, alongside positive net inflows and revenue growth.
Key Events
-
Q4 2025 GAAP EPS Decline
Diluted EPS for the fourth quarter of 2025 was $0.68, a decrease from $0.81 in Q3 2025 and $0.89 in Q4 2024.
-
Impact of Non-Recurring Expenses
GAAP results were significantly impacted by $10.8 million in non-recurring expenses related to a closed-end fund rights offering, which also reduced the operating margin to 28.0%.
-
Stable Adjusted EPS
Adjusted diluted EPS remained stable at $0.81 for Q4 2025, matching Q3 2025 and increasing from $0.78 in Q4 2024.
-
Positive Net Inflows
The company reported $1.2 billion in net inflows for the fourth quarter, contributing to an ending AUM of $90.5 billion.
Analysis
Cohen & Steers reported a notable decline in GAAP diluted EPS for Q4 2025, primarily driven by $10.8 million in non-recurring expenses related to a closed-end fund rights offering. While the GAAP figures show a significant year-over-year and sequential decrease, the adjusted diluted EPS remained stable, and the company achieved positive net inflows and revenue growth. Investors should analyze the adjusted metrics and the one-time nature of the expenses to assess the underlying operational health, as these factors mitigate the headline GAAP miss.
At the time of this filing, CNS was trading at $68.78 on NYSE in the Finance sector, with a market capitalization of approximately $3.5B. The 52-week trading range was $58.39 to $91.07. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.